Ozempic, Wegovy, Mounjaro, Zepbound and the compounded versions
| Product | Molecule (maker) | Approved for | Main trial result | From, at programs we compare |
|---|---|---|---|---|
| Ozempic | Semaglutide (Novo Nordisk) | Type 2 diabetes | Diabetes trials | $349.99/mo at Maximus |
| Wegovy | Semaglutide (Novo Nordisk) | Weight loss; heart-risk reduction; MASH | 14.9% at 68 weeks (STEP 1) | $273/mo at Ro |
| Compounded semaglutide | Semaglutide (licensed pharmacy) | Prepared per prescription | Not separately tested | $59/mo at SnagRx |
| Mounjaro | Tirzepatide (Eli Lilly) | Type 2 diabetes | Diabetes trials | $1,249.99/mo at Maximus |
| Zepbound | Tirzepatide (Eli Lilly) | Weight loss; sleep apnea | 20.9% at 72 weeks (SURMOUNT-1) | $373/mo at Ro |
| Compounded tirzepatide | Tirzepatide (licensed pharmacy) | Prepared per prescription | Not separately tested | $96/mo at yourEra |
Trial numbers: Wegovy and Zepbound prescribing information (STEP 1, SURMOUNT-1); head to head: SURMOUNT-5 (NEJM 2025). Prices read on each program's own site, Nov 12, 2026; lowest plan shown, conditions apply.
How they differ
Semaglutide copies one gut hormone, GLP-1. Tirzepatide is built to act on two, GLP-1 and GIP, which together lower appetite and help blood-sugar control. That dual action is the usual explanation for tirzepatide's larger average weight loss.
Dose numbers don't translate between them. Ozempic tops out at 2 mg and Wegovy at 2.4 mg (plus a higher 7.2 mg dose); tirzepatide runs from 2.5 mg to 15 mg. A 2.5 mg tirzepatide dose is a starting dose, not a strong one.
Why people mix them up
"Ozempic" has become shorthand for every weight-loss shot, the way people say Kleenex for tissues. Both drugs are weekly injections, both cause similar digestive side effects, and both are sold compounded by the same online programs. But they come from competing companies and are different products with different labels.
Which to choose
Choose tirzepatide if you want the larger expected weight loss and the price works for you; choose semaglutide for the lower price, the longer track record or Wegovy's heart-protection approval. In SURMOUNT-5, tirzepatide beat semaglutide by about 6.5 points of body weight at 72 weeks.
On price, compounded versions are the gap-closer: tirzepatide from $96 and semaglutide from $59 a month, vs. $373 for Zepbound. Several programs sell both, so you can start on one and switch with the same clinician.







